FSME-IMMUN Junior susp inj s ai 10 ser pré 0.25 ml

7680006830042 Pharmacode 6286687 CH-683 J07BA01 08.08.
FSME-IMMUN Junior susp inj s ai 10 ser pré 0.25 ml
FSME-IMMUN Junior susp inj s ai 10 ser pré 0.25 ml
FSME-IMMUN Junior susp inj s ai 10 ser pré 0.25 ml
1 / 3
google

Details

GTIN
7680006830042
Pharmacode
6286687
Product number
0068301
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
virus FSME inactivatus (Stamm Neudörfl) 1.19 µg, aluminii hydroxidum hydricum ad adsorptionem corresp. aluminium 0.17 mg, albuminum seri humani, natrii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.25 ml corresp. natrium 0.71 mg et kalium 0.007 mg, residui: saccharum, formaldehydum, protamini sulfas, neomycinum, gentamicinum.

Articles (1)

FSME-Immun 0.25 ml Junior, Injektionssuspension in einer Fertigspritze
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
10/12/2025
Professional SmPC
Français
10/12/2025
Professional SmPC
Italien
10/12/2025

Detailed composition

Substance Quantity Type Category
virus FSME inactivatus
1.19 UG Substance Wirkstoff (Principe actif)
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
aluminium
0.17 MG Substance HNIDK
albuminum seri humani
- Substance HNIDK
natrii chloridum
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.71 MG Substance HBESI
kalium
0.007 MG Substance HBESI
saccharum
- Substance HNIDK
formaldehydum
- Substance HNIDK
protamini sulfas
- Substance HNIDK
neomycinum
- Substance HNIDK
gentamicinum
- Substance HNIDK

Reimbursement information

Public price
CHF 307.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
683
Drug name
FSME-Immun 0.25 ml Junior, Injektionssuspension in einer Fertigspritze
Galenic form
SUPA
ATC Code
J07BA01
Authorization status
Z
Dispensation category
B
First authorization
10/10/2003
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Frühsommer-Meningoenzephalitis, ab dem vollendeten 1. bis zum vollendeten 16. Lebensjahr

Packaging details

Description (FR)
FSME-IMMUN Junior susp inj s ai 10 ser pré 0.25 ml
Description (DE)
FSME-IMMUN Junior Inj Susp o Na 10 Fertspr 0.25 ml
Market launch
10/10/2003
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

FSME-IMMUN Junior susp inj aig sép ser pré 0.25 ml
1 FESP
View
Buy us a coffee Explore the data